CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

Enrolling by invitationOBSERVATIONAL
Enrollment

91,758

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2100

Study Completion Date

December 31, 2100

Conditions
Rheumatoid Arthritis
Trial Locations (1)

02451

CorEvitas, LLC, Waltham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Massachusetts, Worcester

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

CorEvitas

NETWORK